Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes

MLA

Nathalie Labarrière, et al. “Increased Antitumor Efficacy of PD-1-Deficient Melanoma-Specific Human Lymphocytes.” Journal for ImmunoTherapy of Cancer, vol. 8, no. 1, June 2020. EBSCOhost, https://doi.org/10.1136/jitc-2019-000311.

APA

Nathalie Labarrière, Lucine Marotte, Sylvain Simon, Virginie Vignard, Emilie Dupre, Malika Gantier, Jonathan Cruard, Jean-Baptiste Alberge, Melanie Hussong, Cecile Deleine, Jean-Marie Heslan, Jonathan Shaffer, Tiffany Beauvais, Joelle Gaschet, Emmanuel Scotet, Delphine Fradin, & Anne Jarry. (2020). Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. Journal for ImmunoTherapy of Cancer, 8(1). https://doi.org/10.1136/jitc-2019-000311

Chicago

Nathalie Labarrière, Lucine Marotte, Sylvain Simon, Virginie Vignard, Emilie Dupre, Malika Gantier, Jonathan Cruard, et al. 2020. “Increased Antitumor Efficacy of PD-1-Deficient Melanoma-Specific Human Lymphocytes.” Journal for ImmunoTherapy of Cancer 8 (1). doi:10.1136/jitc-2019-000311.